BE660444A - - Google Patents

Info

Publication number
BE660444A
BE660444A BE660444A BE660444A BE660444A BE 660444 A BE660444 A BE 660444A BE 660444 A BE660444 A BE 660444A BE 660444 A BE660444 A BE 660444A BE 660444 A BE660444 A BE 660444A
Authority
BE
Belgium
Prior art keywords
dextran
hydroxyalkyl group
hydroxyalkyl
solution
molecular weight
Prior art date
Application number
BE660444A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL6410005A priority Critical patent/NL6410005A/xx
Application filed filed Critical
Priority to BE660444A priority patent/BE660444A/fr
Publication of BE660444A publication Critical patent/BE660444A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
BE660444A 1965-03-01 1965-03-01 BE660444A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL6410005A NL6410005A (de) 1965-03-01 1964-08-28
BE660444A BE660444A (de) 1965-03-01 1965-03-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE660444A BE660444A (de) 1965-03-01 1965-03-01

Publications (1)

Publication Number Publication Date
BE660444A true BE660444A (de) 1965-09-01

Family

ID=3847337

Family Applications (1)

Application Number Title Priority Date Filing Date
BE660444A BE660444A (de) 1965-03-01 1965-03-01

Country Status (2)

Country Link
BE (1) BE660444A (de)
NL (1) NL6410005A (de)

Also Published As

Publication number Publication date
NL6410005A (de) 1966-03-01

Similar Documents

Publication Publication Date Title
US3453364A (en) Therapeutic infusion and injection composition containing hydroxyalkyl dextran
EP0037319B1 (de) Mukopolysaccharide mit biologischen Eigenschaften, ihre Herstellung und Verwendung als Arzneimittel
EP0593601A1 (de) Taxan-derivate enthaltende arzneimittel
CA2416673C (fr) Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
CA2501546C (fr) Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP0371878A1 (de) Zusammensetzungen zum Überziehen von Futterzusatzmitteln für Wiederkäuer
EP0014490A1 (de) Verfahren zur Trennung von Poly-beta-hydroxybutyraten aus einer Biomasse
JP2006291028A (ja) 低分子ヘパリンまたはその塩、ならびにその製造方法
FR2485019A1 (fr) Glucosaminoglycanes modifies possedant une activite antilipemique et pratiquement exempts d'une activite anti-coagulante
EP0354836A1 (de) Jodhaltige Polymere mit Skeletten von Dextran, Verfahren zu ihrer Herstellung und ihre Verwendungen als Kontrastmittel
BE660444A (de)
CA2533555A1 (fr) Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
CH625124A5 (de)
FR2639639A1 (en) Organosoluble chitosan derivatives, process for their preparation and their uses
EP0209511B1 (de) Hydrochlorid von 2-Aminoalkyl-9-hydroxyellipticinium-Chloridderivaten und diese enthaltende pharmazeutische Zubereitungen
BE898356A (fr) Nouvelle association medicamenteuse a base d'un alcaloide hydrogene de l'ergot de seigle et d'heparine.
EP0699433A2 (de) Kosmetische oder pharmazeutische Zusammensetzung, die Chitosanderivate enthalten
BE1006134A6 (fr) Procede de preparation de derives 2-desoxy-2-amino hexuronyles d'heparine, derives tels qu'ainsi obtenus et leur utilisation.
BE515225A (de)
BE536866A (de)
CH641960A5 (en) Doxorubicin derivatives, their preparation and compositions containing them
FR2666810A1 (fr) Nouveaux 2-acrylamido-2-desoxy-3,6-anhydrohexoses et alkyl-2-acyclamido-3,6-anhydro-hexosides et procede pour les preparer.
BE723548A (de)
BE499168A (de)
BE632574A (de)